Table 3

Baseline characteristics

Weight-based
(n=283)
Glucose-based
(n=292)
Demographic characteristics
Sex (M, %)168 (59.4)168 (57.5)
Age (years)58.9 (8.8)59.7 (9.2)
Diabetes duration (years)6.3 (6.7)7.0 (7.5)
Weight (kg)64.4 (11.4)65.5 (11.8)
BMI (kg/m2)24.4 (3.9)24.7 (3.9)
Clinical characteristics
HbA1c (%)10.9 (2.4)11.1 (2.5)
C-peptide (μg/L)2.2 (2.1)2.0 (1.1)
Admission BG (mmol/L)17.9 (5.3)18.6 (5.4)
Admission diagnosis (n, %)
 Uncontrolled hyperglycemia181 (64.0)179 (61.3)
 DK/DKA45 (15.9)52 (17.8)
 Pneumonia18 (6.4)7 (2.4)
 Urine tract infection24 (8.5)28 (9.6)
 Diabetic foot9 (3.2)17 (5.8)
 Other infections6 (2.1)9 (3.1)
Previous diabetes treatment (n, %)
 None106 (37.5)108 (37.0)
 OHA or GLP-1RA95 (33.6)97 (33.2)
  One type25 (8.8)24 (8.2)
  Two types33 (11.7)31 (10.6)
  Three or over three types37 (13.1)42 (14.4)
 Insulin alone23 (8.1)28 (9.6)
 Both OHA and insulin38 (13.4)37 (12.7)
  • Values are n (%) or mean (SD) unless otherwise stated. Other infection includes upper respiratory infection, skin ulcer and shingles.

  • BG, blood glucose; BMI, body mass index; DK, diabetic ketosis; DKA, diabetic ketoacidosis; GLP-1RA, glucagon-like peptide-1 receptor agonist; HbA1c, hemoglobin A1c; OHA, oral hypoglycemic agent.